ARTICLE SUMMARY:
The big cardiac rhythm management device manufacturers have all invested heavily, and found success, with new “leadless” pacemaker technology and less-invasive implantable defibrillators that avoid common dangers associated with traditional CRM implants.
The three major cardiac rhythm management device companies are all taking slightly different approaches to developing pacemakers and implantable cardioverter defibrillators (ICDs) that, unlike traditional CRM devices, do not require a lead to run from the device generator through a vein and directly into the heart.
